Cargando…
Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
Inflammatory bowel disease (IBD) affects young people of reproductive age. Therefore, a broad discussion is needed about the possible disease effects in pregnancy, as well as the risks of fetal exposure to the medications used, especially biological therapy. This study aimed to describe the manageme...
Autores principales: | Silva, Elen Farinelli de Campos, Baima, Júlio Pinheiro, de Barros, Jaqueline Ribeiro, Renosto, Fernanda Lofiego, de Sibia, Carina de Fatima, Saad-Hossne, Rogério, Sassaki, Ligia Yukie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244106/ https://www.ncbi.nlm.nih.gov/pubmed/30483038 http://dx.doi.org/10.1159/000493921 |
Ejemplares similares
-
Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020) -
Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021) -
Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018) -
Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020) -
Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)